Two molecular pathways to transitional cell carcinoma of the bladder.

作者: David Esrig , Louis Dubeau , Charles H. Spruck , Petra F. Ohneseit , Peter W. Nichols

DOI:

关键词:

摘要: Noninvasive transitional cell carcinomas of the bladder can have two distinct morphologies suggesting they contain different genetic alterations. Papillary (T(a) tumors) are often multifocal and only occasionally progress, whereas flat tumors (carcinomas in situ, CIS), frequently progress to invasive disease. We examined 216 various stages histopathologies for alterations previously described be importance tumorigenesis. Loss heterozygosity chromosome 9 was observed 24 70 (34%) T(a) but present 3 (12%) CIS dysplasia lesions (P = 0.04). In contrast, 1 36 (3%) contained a p53 gene mutation compared 15 23 (65%) dysplasias < 0.001), frequency comparable that muscle (25 49; 51%). The presence mutations could explain their propensities since these known destabilize genome. Analysis several tumor pairs involving an cancer provided evidence alteration may some cases involved progression more tumors, addition its role initiation tumors. However, secondary were found patients divergent pathways. Bladder carcinogenesis therefore proceed through pathways responsible generating superficial with differing pathologies.

参考文章(36)
Catherine A. Reznikoff, Linda J. Loretz, Brian J. Christian, Shi-Qi Wu, Lorraine F. Meisner, Neoplastic transformation of SV40-immortalized human urinary tract epithelial cells by in vitro exposure to 3-methylcholanthrene Carcinogenesis. ,vol. 9, pp. 1427- 1436 ,(1988) , 10.1093/CARCIN/9.8.1427
Paul Cairns, Margaret A. Knowles, Margaret E. Shaw, Preliminary Mapping of the Deleted Region of Chromosome 9 in Bladder Cancer Cancer Research. ,vol. 53, pp. 1230- 1232 ,(1993)
J. Bishop, The molecular genetics of cancer Science. ,vol. 235, pp. 305- 311 ,(1987) , 10.1126/SCIENCE.3541204
Catherine A. Reznikoff, Edward M. Messing, Santhanam Swaminathan, Michael Newton, Chinghai Kao, A molecular genetic model of human bladder carcinogenesis. Seminars in Cancer Biology. ,vol. 4, pp. 143- 152 ,(1993)
Niall M Heney, Susan Ahmed, Malachi J Flanagan, William Frable, Michael P Corder, Mark D Hafermann, Ileana R Hawkins, George R Prout Jr, GH Friedell, DA Culp, S Loening, KB Cummings, SJ Cutler, MJ Flanagan, WW Koontz Jr, H Pearse, C Merrin, Z Wajsman, C Cox, M Soloway, None, Superficial Bladder Cancer: Progression and Recurrence The Journal of Urology. ,vol. 130, pp. 1083- 1086 ,(1983) , 10.1016/S0022-5347(17)51695-X
Cummings Kb, Barone Jg, Ward Ws, Diagnosis and staging of bladder cancer. Urologic Clinics of North America. ,vol. 19, pp. 455- 465 ,(1992) , 10.1016/S0094-0143(21)00413-4
Miller C, Koeffler Hp, P53 mutations in human cancer. Leukemia. ,vol. 7, ,(1993)
P. Rabbitts, R. Rudd, G. Sinha, P. Hasleton, P. Ganly, N. M. Bleehen, V. Sundaresan, p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus Oncogene. ,vol. 7, pp. 1989- 1997 ,(1992)
Lamm Dl, Carcinoma in situ. Urologic Clinics of North America. ,vol. 19, pp. 499- 508 ,(1992)